Home › Research › Disparities
Global burden of Alzheimer’s disease and other dementias (1990–2021): inequality, frontier, and decomposition analysis
Haishou Fu, Huaqing Huang, Shuzhen Liao, Zhisen Dai. Frontiers in Aging Neuroscience, 2025-09-18
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Globally, ADOD incidence, prevalence, and mortality increased significantly between 1990 and 2021 (156.54%, 160.81%, and 194.39%, respectively). High fasting blood glucose was the leading modifiable risk factor, contributing to 14.70% of global ADOD mortality, followed by elevated BMI and tobacco use. Burden trends varied across Socio-Demographic Index (SDI) regions, with high-middle SDI regions showing the highest prevalence. Gender-specific risk factor rankings showed high BMI as the second most significant factor in females, while tobacco use ranked second in males but declined over time. Decomposition analysis revealed the greatest increases in DALYs occurred in middle-SDI regions. This study reveals a considerable potential to reduce the ADOD burden in many countries. Although some metrics have stabilized or slowed in growth, significant inequalities remain, particularly in lower-SDI nations. Tailored strategies focusing on strengthening healthcare systems, targeting high-risk populations, and improving health education are essential to narrow these gaps. Greater international collaboration and open data sharing are also key to building a life-course management model for ADOD prevention and care, ultimately improving global health.
What this study adds
Evidence grade: Low
This global analysis found that Alzheimer's disease and other dementias increased significantly between 1990 and 2021, with high fasting blood glucose as the leading modifiable risk factor contributing to 14.70% of mortality. Reported effect size: 156.54%; 160.81%; 194.39%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Fu, H., Huang, H., Liao, S., & Dai, Z. (2025). Global burden of Alzheimer’s disease and other dementias (1990–2021): inequality, frontier, and decomposition analysis. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2025.1637029
Vancouver
Fu H, Huang H, Liao S, Dai Z. Global burden of Alzheimer’s disease and other dementias (1990–2021): inequality, frontier, and decomposition analysis. Frontiers in Aging Neuroscience. 2025. doi:10.3389/fnagi.2025.1637029. PMID: 41049534.
BibTeX
@article{fu2025-41049534,
author = {Fu, Haishou and Huang, Huaqing and Liao, Shuzhen and Dai, Zhisen},
title = {{Global burden of Alzheimer’s disease and other dementias (1990–2021): inequality, frontier, and decomposition analysis}},
journal = {Frontiers in Aging Neuroscience},
year = {2025},
doi = {10.3389/fnagi.2025.1637029},
pmid = {41049534},
url = {https://doi.org/10.3389/fnagi.2025.1637029}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Globally, ADOD incidence, prevalence, and mortality increased significantly between 1990 and 2021 (156.54%, 160.81%, and 194.39%, respectively).
- High fasting blood glucose was the leading modifiable risk factor, contributing to 14.70% of global ADOD mortality, followed by elevated BMI and tobacco use.
- Burden trends varied across Socio-Demographic Index (SDI) regions, with high-middle SDI regions showing the highest prevalence.
- Gender-specific risk factor rankings showed high BMI as the second most significant factor in females, while tobacco use ranked second in males but declined over time.
- Decomposition analysis revealed the greatest increases in DALYs occurred in middle-SDI regions.
Why it matters
This global analysis found that Alzheimer's disease and other dementias increased significantly between 1990 and 2021, with high fasting blood glucose as the leading modifiable risk factor contributing to 14.70% of mortality. It calls for tailored strategies to strengthen healthcare systems and narrow inequalities, particularly in lower-SDI nations.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Effect size156.54%; 160.81%; 194.39%
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Aging Neuroscience) |
| Journal's citation record | 2 / 4 | Frontiers in Aging Neuroscience: journal h-index 174 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 16 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 10.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 16 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Zhisen Dai: h-index 7 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Fuzhou University: institution h-index 510 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41049534) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fnagi.2025.1637029
- PubMed: 41049534
- Original source →
- Free full text: Frontiers in Aging Neuroscience →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also in Disparities
98 studies in the library are filed under Disparities with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Disparities hub.